Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12116330 | 0.94 | GPR3 (0.39) | KDM4EALDH1A1HPGDHSD17B10CYP1A2 | |
| SCHEMBL12116324 | 0.90 | ALK (0.34) | KDM4EALDH1A1HPGDHSD17B10GLA | |
| SCHEMBL12116328 | 0.88 | PDK2 (0.30) | KDM4EALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL12116293 | 0.88 | KDM4E (0.33) | KDM4EALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL12116329 | 0.87 | GPR3 (0.37) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL21919154 | 0.86 | KDM4E (0.38) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL15582870 | 0.86 | — | — | |
| SCHEMBL12116321 | 0.85 | KIF11 (0.40) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL11922025 | 0.85 | RXRA (0.42) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL11922081 | 0.84 | RXRA (0.38) | KDM4EALDH1A1HPGDHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9434877-B2 | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2016-09-06 | — | — | US | disclosed |
| US-9434877-B2 | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2016-09-06 | — | — | US | disclosed |
| US-20120326141-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2012-12-27 | — | — | US | disclosed |
| US-20120326141-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2012-12-27 | — | — | US | disclosed |
| US-20110272685-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-11-10 | — | — | US | disclosed |
| US-20110272685-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-11-10 | — | — | US | disclosed |
| WO-2010083873-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110272685-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | SLCO4C1, SLCO2A1, SLCO2B1 | KDM4E 3857/4885ALDH1A1 975/4885HPGD 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.